Imatinib decreases endometrial stromal cell transmesothial migration and proliferation in the extracellular matrix of modeled peritoneum

Jason Griffith, Jason S Griffith, Peter Binkley, Peter A Binkley, Namir B Kirma, Robert S Schenken, Craig A Witz, Rajeshwar R Tekmal
Fertility and sterility · 2010 · vol. 94(7) , pp. 2531–2535 · doi:10.1016/j.fertnstert.2010.04.018 · PMID:20553674 · W2115476730
article OA: closed CC0 ⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Imatinib treatment reduced endometrial stromal cell transmesothelial migration and proliferation within the extracellular matrix of a modeled peritoneal environment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Cell Proliferation Endometrium Extracellular Matrix Peritoneum Piperazines Pyrimidines Stromal Cells Transendothelial and Transepithelial Migration Antineoplastic Agents Antineoplastic Agents Benzamides Cell Adhesion Cell Adhesion Cell Adhesion Cell Culture Techniques Cell Proliferation Cells, Cultured Down-Regulation Down-Regulation Drug Evaluation, Preclinical

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Cited by (6)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:07.008521+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK